Concomitant Delivery of Paclitaxel and NuBCP-9 peptide for synergistic enhancement of cancer therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Concomitant Delivery of Paclitaxel and NuBCP-9 peptide for synergistic enhancement of cancer therapy

Published:2018-06 Issue:4 Volume:14 Page:1301-1313
ISSN:1549-9634
Container-title:Nanomedicine: Nanotechnology, Biology and Medicine
language:en
Short-container-title:Nanomedicine: Nanotechnology, Biology and Medicine

Author:

Gupta Dikshi,Kumar Manoj,Tyagi Priyanka,Kapoor Sumeet,Tyagi Amit,Barman Tarani Kanta,Kharbanda Surender,Kufe Donald,Singh Harpal

Publisher

Elsevier BV

Subject

Pharmaceutical Science,General Materials Science,Biomedical Engineering,Molecular Medicine,Medicine (miscellaneous),Bioengineering

Reference51 articles.

1. Phase II trial of taxol, an active drug in the treatment of metastatic breast cancer;Holmes;J Natl Cancer Inst,1991

2. A phase I trial of taxol given by a 6-hour intravenous infusion;Brown;J Clin Oncol,1991

3. Taxol: a unique antineoplastic agent with significant activity in advanced ovarian epithelial neoplasms;Mc Guire;Ann Intern Med,1989

4. How do microtubule-targeted drugs work? An overview;Jordan;Curr Cancer Drug Targets,2007

5. Cytologic evidence that taxol, an antineoplastic agent from Taxusbrevifolia, acts as a mitotic spindle poison;Fuchs;Cancer Treat Rep,1978

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancements in precision nanomedicine design targeting the anoikis-platelet interface of circulating tumor cells;Acta Pharmaceutica Sinica B;2024-08

2. Small Molecule Functional Converter of B-Cell Lymphoma-2 (Bcl-2) Suppresses Breast Cancer Lung Metastasis;ACS Pharmacology & Translational Science;2024-05-01

3. Co-delivery of siBcl-2 and PTX with mitochondria-targeted functions to overcoming multidrug resistance;International Journal of Pharmaceutics;2024-04

4. Identification and Characterization of a Small Molecule Bcl-2 Functional Converter;Cancer Research Communications;2024-03-04

5. Peptide-based strategies for overcoming multidrug-resistance in cancer therapy;Chinese Chemical Letters;2024-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3